Point72 Asset Management, L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:27 pm Sale | 2026-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Point72 Asset Management, L.P. | 643,599 1.200% | -2,338,075 (-78.41%) | Filing |
| 2026-02-17 4:35 pm Purchase | 2025-12-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Point72 Asset Management, L.P. | 2,981,674 6.900% | 860,534 (+40.57%) | Filing |
| 2025-09-12 4:10 pm Purchase | 2025-09-11 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Point72 Asset Management, L.P. | 2,121,140 5.300% | 675,315 (+46.71%) | Filing |
| 2025-08-14 5:33 pm Sale | 2025-06-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Point72 Asset Management, L.P. | 1,445,825 4.500% | -448,479 (-23.68%) | Filing |
| 2025-04-17 4:10 pm Purchase | 2025-04-10 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Point72 Asset Management, L.P. | 1,894,304 5.900% | 1,894,304 (New Position) | Filing |